News
I wrote a bullish article about Canadian insurer Trisura (OTCPK:TRRSF) (TSX:TSU:CA) 2.5 years ago. At the time of writing, the stock price was about...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
News
This article was written by Follow The Value Portfolio specializes in building retirement portfolios and utilizes a fact-based research strategy to identify investments. This...
News
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
News
While the cause of Maui’s heartbreaking fire remains under investigation, this much is clear: It will forever be remembered as one of the greatest...
News
As the student loan pause ends in a matter of days, borrowers are facing a number of critical deadlines. There may be only a...
News
Build-A-Bear Workshop, Inc. (NYSE:BBW) Q2 2023 Results Conference Call August 24, 2023 9:00 AM ET Company Participants Gary Schnierow – VP, IR & Corporate...
News
Osisko Gold Royalties: Investors Should Be Thrilled This article breaks down Osisko’s second quarter earnings and also discusses a recent positive news release discussing...
News
U.S. mortgage rates increased for the fifth week in a row, with the 30-year reaching the highest level since 2001. The 30-year fixed-rate mortgage...
News
Opera Limited (NASDAQ:OPRA) Q2 2023 Earnings Conference Call August 24, 2023 8:00 AM ET Company Participants Matthew Wolfson – Head of Investor Relations Lin...
News
Palantir (NYSE:PLTR) is in the process of developing software platforms for governments and enterprises to integrate their data, decisions, and operations at scale. I...
News
In this article, we take a look at the TriplePoint Venture Growth (NYSE:TPVG) BDC. The company is one we have avoided in our Income...
News
Nanobiotix (NASDAQ:NBTX) is a clinical stage French company developing cancer treatments that use proprietary nanotechnology. Lead asset NBTXR3 is a radioenhancer, a “suspension of...
